Table 1.
Composition | kobs (min−1) | t1/2 (min) |
---|---|---|
No additives | 0.1322 ± 0.0011 | 5.24 ± 0.04 |
E-SD 0.2 mg/mL | 0.0925 ± 0.0013 | 7.49 ± 0.10 |
E-SD 0.5 mg/mL | 0.0794 ± 0.0006 | 8.73 ± 0.07 |
E-SD 1 mg/mL | 0.0345 ± 0.0005 | 20.07 ± 0.29 |
E-SD 2 mg/mL | 0.0219 ± 0.0004 | 31.65 ± 0.58 |
E-SD 5 mg/mL | 0.0125 ± 0.0005 | 55.64 ± 2.02 |
HPMC 2 mg/mL | 0.1319 ± 0.0020 | 5.25 ± 0.08 |
TPGS 0.2 mg/mL | 0.0225 ± 0.0009 | 30.83 ± 1.16 |
The pseudo-first-order rate constants (kobs) and half-life (t1/2) were calculated according to the equations ln[Ct] = ln[C0] − kobs·t and t1/2 = 0.693/kobs, respectively. [C0] is the initial concentration of sirolimus and [Ct] is the percentage remaining at time t, which allowed for the calculation of kobs as the slopes of the lines obtained by linear regression analysis. Data are expressed as the mean ± standard deviation (n = 3).